GlassScriptPhysician profile
Ihtsham Haq
NPI 1720154008
$11,470.32
in general payments reported to CMS, 2019-2025
9 companies · $2,741 in 2025
The $2,741 reported for 2025 was more than what 78% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,245 · 2021: $2,741 · 2022: $577 · 2023: $487 · 2024: $679 · 2025: $2,741.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,353 · Travel and Lodging: $1,555.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,352.60 |
| Travel and Lodging | $1,554.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $5,087.53 | 2019-2025 | General - Dbs, Vercise |
| Medtronic, INC. | $2,775.40 | 2021-2024 | Percept PC Brainsense |
| Insightec,INC | $2,248.34 | 2025 | Exablate |
| Abbott Laboratories | $465.07 | 2021-2022 | |
| Amneal Pharmaceuticals LLC | $309.95 | 2025 | Crexont |
| Neurocrine Biosciences, INC. | $228.09 | 2022-2024 | Ingrezza |
| Novartis Pharmaceuticals Corporation | $204.93 | 2023-2025 | |
| Ge Healthcare | $135.69 | 2023 | |
| Abbvie INC. | $15.32 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ihtsham Haq listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.